Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 2
1990 2
1993 6
1994 6
1995 4
1996 5
1997 4
1998 3
1999 2
2000 3
2001 5
2002 6
2003 2
2004 1
2005 1
2006 6
2007 7
2008 11
2009 5
2010 7
2011 8
2012 15
2013 13
2014 12
2015 10
2016 11
2017 13
2018 5
2019 9
2020 21
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Results by year
Filters applied: . Clear all
Page 1
Is hypervascular papillary renal cell carcinoma present?
Yamamoto T, Gulanbar A, Hayashi K, Kohno A, Komai Y, Yonese J, Matsueda K, Inamura K. Yamamoto T, et al. Among authors: yonese j. Abdom Radiol (NY). 2021 Apr;46(4):1687-1693. doi: 10.1007/s00261-020-02809-8. Epub 2020 Oct 12. Abdom Radiol (NY). 2021. PMID: 33047228
Biomarkers to predict prognosis and response to checkpoint inhibitors.
Yuasa T, Masuda H, Yamamoto S, Numao N, Yonese J. Yuasa T, et al. Among authors: yonese j. Int J Clin Oncol. 2017 Aug;22(4):629-634. doi: 10.1007/s10147-017-1122-1. Epub 2017 Apr 5. Int J Clin Oncol. 2017. PMID: 28382562 Free PMC article. Review.
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review.
Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Kijima T, et al. Among authors: yonese j. Clin Genitourin Cancer. 2021 Jun;19(3):208-216.e1. doi: 10.1016/j.clgc.2020.07.003. Epub 2020 Jul 16. Clin Genitourin Cancer. 2021. PMID: 32800718 Review.
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.
Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Kijima T, et al. Among authors: yonese j. Cancer Immunol Immunother. 2021 Mar;70(3):657-665. doi: 10.1007/s00262-020-02709-2. Epub 2020 Sep 2. Cancer Immunol Immunother. 2021. PMID: 32876736
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page